Keeping you up to date on recent developments in neurology, including: Novel drug delivery particles use neurotransmitters as a 'passport' into the brain; SARS-CoV-2 infection of non-neuronal cells, not neurons, may drive loss of smell in patients with COVID-19; Pandemic to accelerate adoption of electronic patient portal for epilepsy.
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Bionano Genomics, Codex DNA, Empirical Spine, Gs, Helixbind, Nuvasive, Oncocyte, Perfectprime, Personalis, Progenetics, Vectracor.
The U.S. government has charged two citizens of China with cybercrime in connection with purported hacking of research into vaccines for the SARS-CoV-2 virus, but more than one speaker on a July 22 webinar said scientists involved in basic life science research at universities fail to appreciate the need for cybersecurity, a problem they may take with them to the private sector.
LONDON – There were encouraging results from trials of three COVID-19 vaccines on July 20, with Astrazeneca plc, Biontech SE/Pfizer Inc. and Cansino Biologics Inc. all reporting T-cell responses in ongoing phase I/II studies of their respective products.
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Boston Scientific, Channel Medsystems, Lifesignals, OralDNA Labs, Paige.
